>>The industry argues that production of coronavirus vaccines is difficult and cannot be increased by easing intellectual property protections. Instead, it says that reducing problems in supply chains as well as the lack of vaccine ingredients are the most important problems right now.
>>The industry argues that production of coronavirus vaccines is difficult and cannot be increased by easing intellectual property protections. Instead, it says that reducing problems in supply chains as well as the lack of vaccine ingredients are the most important problems right now.
このブックマークにはスターがありません。
最初のスターをつけてみよう！
More Support Easing Vaccine Patent Rules, But Problems Remain
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／